Two-Drug HIV Therapy Effective Without Resistance Testing
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with HIV without preliminary drug resistance testing in a phase 4 trial.
Medscape Medical News
source https://www.medscape.com/viewarticle/two-drug-hiv-regimen-matches-standard-care-therapy-absence-2025a10006aw?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/two-drug-hiv-regimen-matches-standard-care-therapy-absence-2025a10006aw?src=rss
Comments
Post a Comment